Prevalence of Long‐Term Opioid Use in Long‐Stay Nursing Home Residents
Open Access
- 21 September 2017
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 66 (1), 48-55
- https://doi.org/10.1111/jgs.15080
Abstract
Background/Objectives Overall and long‐term opioid use among older adults have increased since 1999. Less is known about opioid use in older adults in nursing homes (NHs). Design Cross‐sectional. Setting U.S. NHs (N = 13,522). Participants Long‐stay NH resident Medicare beneficiaries with a Minimum Data Set 3.0 (MDS) assessment between April 1, 2012, and June 30, 2012, and 120 days of follow‐up (N = 315,949). Measurements We used Medicare Part D claims to measure length of opioid use in the 120 days from the index assessment (short‐term: ≤30 days, medium‐term: >30–89 days, long‐term: ≥90 days), adjuvants (e.g., anticonvulsants), and other pain medications (e.g., corticosteroids). MDS assessments in the follow‐up period were used to measure nonpharmacological pain management use. Modified Poisson models were used to estimate adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) for age, gender, race and ethnicity, cognitive and physical impairment, and long‐term opioid use. Results Of all long‐stay residents, 32.4% were prescribed any opioid, and 15.5% were prescribed opioids long‐term. Opioid users (versus nonusers) were more commonly prescribed pain adjuvants (32.9% vs 14.9%), other pain medications (25.5% vs 11.0%), and nonpharmacological pain management (24.5% vs 9.3%). Long‐term opioid use was higher in women (aPR = 1.21, 95% CI = 1.18–1.23) and lower in racial and ethnic minorities (non‐Hispanic blacks vs whites: APR = 0.93, 95% CI = 0.90–0.94) and those with severe cognitive impairment (vs no or mild impairment, aPR = 0.82, 95% CI = 0.79–0.83). Conclusion One in seven NH residents was prescribed opioids long‐term. Recent guidelines on opioid prescribing for pain recommend reducing long‐term opioid use, but this is challenging in NHs because residents may not benefit from nonpharmacological and nonopioid interventions. Studies to address concerns about opioid safety and effectiveness (e.g., on pain and functional status) in NHs are needed.Funding Information
- National Institutes of Health (1TL1TR001454, 1R56NR015498–01)
This publication has 45 references indexed in Scilit:
- The Association Between Pain and Measures of Well-Being Among Nursing Home ResidentsJournal of the American Medical Directors Association, 2012
- Age and Gender Trends in Long-Term Opioid Analgesic Use for Noncancer PainAmerican Journal of Public Health, 2010
- A Flood of Opioids, a Rising Tide of DeathsThe New England Journal of Medicine, 2010
- Outcomes Associated with Opioid Use in the Treatment of Chronic Noncancer Pain in Older Adults: A Systematic Review and Meta‐AnalysisJournal of the American Geriatrics Society, 2010
- Medicare Part D's Exclusion of Benzodiazepines and Fracture Risk in Nursing HomesJAMA Internal Medicine, 2010
- Pharmacological Management of Persistent Pain in Older PersonsJournal of the American Geriatrics Society, 2009
- De Facto Long-term Opioid Therapy for Noncancer PainThe Clinical Journal of Pain, 2008
- Persistent Nonmalignant Pain and Analgesic Prescribing Patterns in Elderly Nursing Home ResidentsJournal of the American Geriatrics Society, 2004
- The Management of Persistent Pain in Older PersonsJournal of the American Geriatrics Society, 2002
- Scaling ADLs Within the MDSThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 1999